Global Immune Repertoire Sequencing Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast, 2022-2030

The global immune repertoire sequencing market size was valued at US $114.3 million in 2020 and is expected to witness a CAGR of 5.6% over the forecast period of 20212028. Immune repertoire sequencing is extensively used in biomarker discovery to improve the success rate and cost-effectiveness of rational drug development. In November 2017, the Center for Commercialization of Cancer Immunotherapy (C3i) started offering T cell receptor-beta sequencing services in its biomarker and diagnostic unit in Canada. Increasing demand for personalized medicine, in turn, is expected to aid the immune repertoire sequencing market growth, as personalized medicine uses an individuals genetic profile to guide decisions made regarding the diagnosis, prevention, and treatment of diseases.
Top Driver: an increasing number of cases related to cancer will drive the markets growth.
Immune repertoire sequencing is used in many different applications, including biomarker discovery, cancer immunotherapy, asthma and allergy research, infectious disease research, and many others.The use of immune repertoire sequencing is growing due to the increased number of launches of novel products, R&D for product development, increasing the number of cases related to cancer, increasing government funding, and more, which will act as a driver for the growth of the market. Various organisations are also aiming to look for solutions with regards to biomarkers in the immune system, which will further create new opportunities for the immune repertoire sequencing market in the forecast period of 20192028.

Increasing Research & Development to Make Crucial Contribution to the Growth of Global Immune Receptor Sequencing
Increasing Research and Development and Demand for Genomic and Repertoire Sequencing-based Research are expected to Drive the Growth of the Immune Repertoire Sequencing Market. Increasing research and development and launches of novel products by key players are expected to be the major driving forces for global immune repertoire sequencing market growth in the near future. For instance, in 2016, ArcherDX, Inc. expanded its product portfolio with the launch of Archer Immunoverse immune repertoire sequencing assays at the American Society of Hematology (ASH). In 2017, ArcherDX, Inc. launched Archer Immunoverse B Cell Receptor (BCR) assays to characterize the human B cell repertoire.
North America is dominated by witnessing the fastest growth in global immune repertoire sequencing.
On the basis of region, the global immune repertoire sequencing market is segmented into North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa. Due to the high presence of key industry players in the region (including Illumina Inc., Thermo Fisher Scientific, Pacific Biosciences, and CD Genomics), North America is expected to hold a dominant position in the global immune repertoire sequencing market during the forecast period. These players are increasingly focusing on the development of novel technologies for immune repertoire sequencing.

Europe is expected to witness rapid growth in the immune repertoire sequencing market. The market in Europe is expected to gain momentum during the forecast period, owing to a rise in funding by government bodies to support international innovative projects and marketable innovative products, processes, and services in order to cater to unmet medical needs. In July 2018, Eurostars (a joint programme between EUREKA and the European Commission) granted US $495,000.00 to OSE Immunotherapeutic SAs project entitled: """"Treatment Response Monitoring for Cancer Immunotherapies Using Immune Repertoire Analysis.""""
Players to Focus on immune repertoire sequencing

Key players operating in the global immune repertoire sequencing market include<
b>
Thermo Fisher Scientific, Inc.
Illumina Inc.
ArcherDX, Inc.
Roche Holding AG
Pacific Biosciences
CD Genomics
Atreca, Inc.
Adaptive Biotechnologies
Oxford Nanopore Technologies, Ltd.
Qiagen N.V.
Agilent Technologies, Inc.
Takara Bio, Inc.
For instance, in 2017, 10x Genomics Inc., U.S. based company, added B-Cell and 5Unbiased Enrichment Kit to its chromium immune repertoire profiling solution or immune repertoire sequencing.
Scope of the Report

By Sequencing
Semiconductor Sequencing
Pyro-Sequencing
Dye-Terminating Sequencing
By Application
Transplant Rejection & Tolerance
Vaccine Development & Efficacy
Biomarker Discovery
Autoimmune Disease
Infectious Diseases
Cancer Immunotherapy

By End-User
Research Centers
Diagnostic Labs
By Region
North America
Europe
Asia Pacific
Rest Of World


Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation

Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted

Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary

Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis

Chapter 5 Global Immune repertoire sequencing Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition

Chapter 6 Global Immune repertoire sequencing Market -Industry Snapshots
6.1 Overview
6.1.1 Global Immune repertoire sequencing Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis.

Chapter 7 Global Immune repertoire sequencing Market Analysis, by Sequencing
7.1 Overview
7.2 Key Findings for Immune repertoire sequencing Market- By Sequencing
7.2.1 Immune repertoire sequencing Market- Semiconductor Sequencing
7.2.2 Immune repertoire sequencing Market- Pyro-Sequencing
Immune repertoire sequencing market by Sequencing 2, 2019 - 2028 (USD Million)
7.2.3 Immune repertoire sequencing Market- Dye-Terminating Sequencing

Chapter 8 Global Immune repertoire sequencing Market Analysis, by Application
8.1 Overview
8.2 Key Findings for Immune repertoire sequencing Market- By Product Type
8.2.1 Immune repertoire sequencing Market- Transplant Rejection & Tolerance
8.2.2 Immune repertoire sequencing Market- Vaccine Development & Efficacy
Immune repertoire sequencing market by Product Type 2, 2019 - 2028 (USD Million)
8.2.3 Immune repertoire sequencing Market- Biomarker Discovery
Immune repertoire sequencing market by Product Type 3, 2019 - 2028 (USD Million)
8.2.4 Immune repertoire sequencing Market- Autoimmune Disease

Chapter 9 Global Immune repertoire sequencing Market Analysis, by End User
9.1 Overview
9.2 Key Findings for Immune repertoire sequencing Market- By End User
9.2.1 Immune repertoire sequencing Market- Research Centers
9.2.2 Immune repertoire sequencing Market- Diagnostic Labs
Immune repertoire sequencing market by End User 2, 2019 - 2028 (USD Million)

Chapter 10 Immune repertoire sequencing Market Analysis by Region
10.1 Key Findings for Immune repertoire sequencing Market- By region
10.2 Overview
10.2.1 Global Immune repertoire sequencing Market Analysis, By Type, 2019 - 2028
10.2.2 Global Immune repertoire sequencing Market Analysis, By Product Type, 2019 - 2028
10.2.3 Global Immune repertoire sequencing Market Analysis, By End User, 2019 - 2028
10.3 Immune repertoire sequencing Market North America
10.3.1 Overview
10.3.2 U.S.
10.3.3 Canada
10.3.4 Mexico
10.3.5 North America Market, By Type
10.3.6 North America Market, By Product Type
10.3.7 North America Market, By End User
10.4 Immune repertoire sequencing Market Europe
10.4.1 Overview
10.4.2 Germany
10.4.3 United Kingdom
10.4.4 France
10.4.5 Italy
10.4.6 Rest Of Europe
10.4.7 Europe Market, By Type
10.4.8 Europe Market, By Product Type
10.4.9 Europe market by, End User
10.5 Immune repertoire sequencing Market Asia Pacific
10.5.1 Overview
10.5.2 China
10.5.3 Japan
10.5.4 India
10.5.5 Rest of APAC
10.5.6 Asia Pacific Market, By Type
10.5.7 Asia Pacific Market, By Product Type
10.5.8 Asia Pacific Market, By End User
10.6 Immune repertoire sequencing Market Rest Of World
10.6.1 Overview
10.6.2 Middle East & Africa (MEA)
10.6.3 Latin America
10.6.4 Rest Of World
10.6.5 Latin America, Middle East and Africa Market, By Type
10.6.6 Latin America, Middle East and Africa Market, By Product Type
10.6.7 Latin America, Middle East and Africa Market, By End User

Chapter 11 Market Competition Analysis
11.1 Market Share/Positioning Analysis
11.1.1 Market Positioning of Key Vendors, 2019
11.1.2 Key Strategies Adopted by the Leading Players
11.1.3 Recent Developments

Chapter 12 Company Profiles- Snapshot
12.1 The Dow Chemical Company
12.1.1 Business Fundamentals
12.1.2 Financial Snapshots
12.1.3 Product Portfolio
12.1.4 Recent Developments
12.2 China Petrochemical Corporation (Sinopec)
12.3 BASF SE
12.4 Borealis AG
12.5 Covestro AG
12.6 Lanxess
12.7 Chevron Phillips Chemical Company LLC
12.8 Company 1
12.9 Company 2
12.10 Company 2
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies

Chapter 13 Appendix

List Of Tables

TABLE 1 Immune repertoire sequencing market by Sequencing 1, 2019 - 2028 (USD Million)
TABLE 2 Immune repertoire sequencing market by Sequencing 3, 2019 - 2028 (USD Million)
TABLE 3 Immune repertoire sequencing market by Product Type 1, 2019 - 2028 (USD Million)
TABLE 4 Immune repertoire sequencing market by Product Type 4, 2019 - 2028 (USD Million)
TABLE 5 Immune repertoire sequencing market by End User 1, 2019 - 2028 (USD Million)
TABLE 6 Global Immune repertoire sequencing Market Value, By Type, 2019 - 2028 (US$ Bn)
TABLE 7 Global Immune repertoire sequencing Market Value, By Product Type, 2019 - 2028 (US$ Bn)
TABLE 8 Global Immune repertoire sequencing Market Value, By End User, 2019 - 2028 (US$ Bn)
TABLE 9 Immune repertoire sequencing Market Analysis by North America (USD Million), 2019 - 2028
TABLE 10 U.S. Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 11 U.S. Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 12 U.S. Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 13 U.S. Immune repertoire sequencing Market, By End User, 2019 - 2028 (USD Million)
TABLE 14 Canada Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 15 Canada Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 16 Canada Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 17 Canada Immune repertoire sequencing Market, By End User, 2019 - 2028 (USD Million)
TABLE 18 Mexico Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 19 Mexico Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 20 Mexico Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 21 Mexico Immune repertoire sequencing Market, By End User, 2019 - 2028 (USD Million)
TABLE 22 Immune repertoire sequencing Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 23 Germany Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 24 Germany Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 25 Germany Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 26 Germany Immune repertoire sequencing Market, By End User, 2019 - 2028 (USD Million)
TABLE 27 United Kingdom Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 28 United Kingdom Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 29 United Kingdom Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 30 United Kingdom Immune repertoire sequencing Market, By End User, 2019 - 2028 (USD Million)
TABLE 31 France Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 32 France Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 33 France Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 34 France Immune repertoire sequencing Market, By End User, 2019 - 2028 (USD Million)
TABLE 35 Italy Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 36 Italy Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 37 Italy Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 38 Italy Immune repertoire sequencing Market, By End User, 2019 - 2028 (USD Million)
TABLE 39 Rest Of Europe Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 40 Rest Of Europe Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 41 Rest Of Europe Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 42 Rest of Europe Immune repertoire sequencing Market, By End User, 2019 - 2028 (USD Million)
TABLE 43 Immune repertoire sequencing Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 44 China Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 45 China Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 46 China Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 47 China Immune repertoire sequencing Market, By End User, 2019 - 2028 (USD Million)
TABLE 48 Japan Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 49 Japan Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 50 Japan Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 51 Japan Immune repertoire sequencing Market, By End User, 2019 - 2028 (USD Million)
TABLE 52 India Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 53 India Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 54 India Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 55 India Immune repertoire sequencing Market, By End User, 2019 - 2028 (USD Million)
TABLE 56 Rest of APAC Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 57 Rest of APAC Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 58 Rest of APAC Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 59 Rest of APAC Immune repertoire sequencing Market, By End User, 2019 - 2028 (USD Million)
TABLE 60 Immune repertoire sequencing Market Analysis by Rest Of World (USD Million), 2019 - 2028
TABLE 61 Middle East & Africa (MEA) Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 62 Middle East & Africa (MEA) Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 63 Middle East & Africa (MEA) Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 64 Middle East & Africa (MEA) Market, By End User, 2019 - 2028 (USD Million)
TABLE 65 Latin America Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 66 Latin America Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 67 Latin America Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 68 Latin America Immune repertoire sequencing Market, By End User, 2019 - 2028 (USD Million)
TABLE 69 Rest Of World Immune repertoire sequencing Market, 2019 - 2028 (USD Million)
TABLE 70 Rest Of World Immune repertoire sequencing Market, By Type, 2019 - 2028 (USD Million)
TABLE 71 Rest Of World Immune repertoire sequencing Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 72 Rest Of World Immune repertoire sequencing Market, By End User, 2019 - 2028 (USD Million)
Chapter 1

List Of Figures

FIG. 1 Global Immune repertoire sequencing: Market Segmentation
FIG. 2 Global Immune repertoire sequencing Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Immune repertoire sequencing Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Immune repertoire sequencing Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Immune repertoire sequencing Market Value Contribution, By Product Type, 2019 & 2026 (%)
FIG. 10 Global Immune repertoire sequencing Market Value Contribution, By End User, 2019 & 2026 (%)
FIG. 11 Global Immune repertoire sequencing Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 North America Immune repertoire sequencing Market Value, 2019 - 2028, (US$ Bn)
FIG. 13 Immune repertoire sequencing Market Segment 1 North America
FIG. 14 Immune repertoire sequencing Market Segment 2 North America
FIG. 15 Immune repertoire sequencing Market Segment 3 North America
FIG. 16 Immune repertoire sequencing U.S. outlook, 2019 & 2026
FIG. 17 Immune repertoire sequencing Canada outlook, 2019 & 2026
FIG. 18 Immune repertoire sequencing Mexico outlook, 2019 & 2026
FIG. 19 Europe Immune repertoire sequencing Market Value, 2019 - 2028, (US$ Bn)
FIG. 20 Immune repertoire sequencing Market Segment 1 Europe
FIG. 21 Immune repertoire sequencing Market Segment 2 Europe
FIG. 22 Immune repertoire sequencing Market Segment 3 Europe
FIG. 23 Immune repertoire sequencing Germany outlook, 2019 & 2026
FIG. 24 Immune repertoire sequencing United Kingdom outlook, 2019 & 2026
FIG. 25 Immune repertoire sequencing France outlook, 2019 & 2026
FIG. 26 Immune repertoire sequencing Italy outlook, 2019 & 2026
FIG. 27 Immune repertoire sequencing Rest Of Europe outlook, 2019 & 2026
FIG. 28 Asia Pacific Immune repertoire sequencing Market Value, 2019 - 2028, (US$ Bn)
FIG. 29 Immune repertoire sequencing Market Segment 1 Asia Pacific
FIG. 30 Immune repertoire sequencing Market Segment 2 Asia Pacific
FIG. 31 Immune repertoire sequencing Market Segment 2 Asia Pacific
FIG. 32 Immune repertoire sequencing China outlook, 2019 & 2026
FIG. 33 Immune repertoire sequencing Japan outlook, 2019 & 2026
FIG. 34 Immune repertoire sequencing India outlook, 2019 & 2026
FIG. 35 Immune repertoire sequencing Rest of APAC outlook, 2019 & 2026
FIG. 36 Rest Of World Immune repertoire sequencing Market Value, 2019 - 2028, (US$ Bn)
FIG. 37 Immune repertoire sequencing Market Segment 1 Rest Of World
FIG. 38 Immune repertoire sequencing Market Segment 2 Rest Of World
FIG. 39 Immune repertoire sequencing Market Segment 3 Rest Of World
FIG. 40 Immune repertoire sequencing Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 41 Immune repertoire sequencing Latin America outlook, 2019 & 2026
FIG. 42 Immune repertoire sequencing Rest Of World outlook, 2019 & 2026

FIG. 1 Global Immune repertoire sequencing: Market Segmentation
FIG. 2 Global Immune repertoire sequencing Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Immune repertoire sequencing Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Immune repertoire sequencing Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Immune repertoire sequencing Market Value Contribution, By Product Type, 2019 & 2026 (%)
FIG. 10 Global Immune repertoire sequencing Market Value Contribution, By End User, 2019 & 2026 (%)
FIG. 11 Global Immune repertoire sequencing Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 North America Immune repertoire sequencing Market Value, 2019 - 2028, (US$ Bn)
FIG. 13 Immune repertoire sequencing Market Segment 1 North America
FIG. 14 Immune repertoire sequencing Market Segment 2 North America
FIG. 15 Immune repertoire sequencing Market Segment 3 North America
FIG. 16 Immune repertoire sequencing U.S. outlook, 2019 & 2026
FIG. 17 Immune repertoire sequencing Canada outlook, 2019 & 2026
FIG. 18 Immune repertoire sequencing Mexico outlook, 2019 & 2026
FIG. 19 Europe Immune repertoire sequencing Market Value, 2019 - 2028, (US$ Bn)
FIG. 20 Immune repertoire sequencing Market Segment 1 Europe
FIG. 21 Immune repertoire sequencing Market Segment 2 Europe
FIG. 22 Immune repertoire sequencing Market Segment 3 Europe
FIG. 23 Immune repertoire sequencing Germany outlook, 2019 & 2026
FIG. 24 Immune repertoire sequencing United Kingdom outlook, 2019 & 2026
FIG. 25 Immune repertoire sequencing France outlook, 2019 & 2026
FIG. 26 Immune repertoire sequencing Italy outlook, 2019 & 2026
FIG. 27 Immune repertoire sequencing Rest Of Europe outlook, 2019 & 2026
FIG. 28 Asia Pacific Immune repertoire sequencing Market Value, 2019 - 2028, (US$ Bn)
FIG. 29 Immune repertoire sequencing Market Segment 1 Asia Pacific
FIG. 30 Immune repertoire sequencing Market Segment 2 Asia Pacific
FIG. 31 Immune repertoire sequencing Market Segment 2 Asia Pacific
FIG. 32 Immune repertoire sequencing China outlook, 2019 & 2026
FIG. 33 Immune repertoire sequencing Japan outlook, 2019 & 2026
FIG. 34 Immune repertoire sequencing India outlook, 2019 & 2026
FIG. 35 Immune repertoire sequencing Rest of APAC outlook, 2019 & 2026
FIG. 36 Rest Of World Immune repertoire sequencing Market Value, 2019 - 2028, (US$ Bn)
FIG. 37 Immune repertoire sequencing Market Segment 1 Rest Of World
FIG. 38 Immune repertoire sequencing Market Segment 2 Rest Of World
FIG. 39 Immune repertoire sequencing Market Segment 3 Rest Of World
FIG. 40 Immune repertoire sequencing Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 41 Immune repertoire sequencing Latin America outlook, 2019 & 2026
FIG. 42 Immune repertoire sequencing Rest Of World outlook, 2019 & 2026

Companies Mentioned

Thermo Fisher Scientific Inc.
ArcherDX Inc.
Illumina Inc.
Roche Holding AG
CD Genomics
Atreca Inc.
Oxford Nanopore Technologies Ltd.
Qiagen N.V.
Agilent Technologies Inc.
Takara Bio Inc.



Thermo Fisher Scientific Inc.
ArcherDX Inc.
Illumina Inc.
Roche Holding AG
CD Genomics
Atreca Inc.
Oxford Nanopore Technologies Ltd.
Qiagen N.V.
Agilent Technologies Inc.
Takara Bio Inc.


2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations

2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The

USD 7500 View Report

2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities

2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any

USD 2450 View Report

COVID-19 Outbreak-Global Immune Health Supplements Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

The Immune Health Supplements market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.Under COVID-19 outbreak globally,

USD 3660 View Report

COVID-19 Outbreak-Global Immune Checkpoint Inhibitors Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

The Immune Checkpoint Inhibitors market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.Under COVID-19 outbreak globally,

USD 3660 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available